genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX 1.244
+0.044 (3.67%)
Aug 17, 2026, 3:51 PM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 19.27 million as of August 17, 2026. Its market cap has increased by 319.48% in one year.
Market Cap
19.27M
Enterprise Value
19.38M
Revenue
1.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.24
ChartMarket Cap Chart
Since April 10, 2007, genedrive's market cap has increased from 11.67M to 19.27M, an increase of 65.09%. That is a compound annual growth rate of 2.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 19.27M | 113.86% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 72.83B |
| Haleon | 31.32B |
| Smith & Nephew | 9.22B |
| Arecor Therapeutics | 22.47M |
| Renalytix | 17.92M |
| Inspiration Healthcare Group | 16.59M |
| RUA Life Sciences | 16.45M |